Oxidative stress and redox-active iron in Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 1012, Issue , 2004, Pages 179-182

  Honda, Kazuhiro ^a   Casadesus, Gemma ^a   Petersen, Robert B ^a   Perry, George ^a   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Iron; Mitochondria; Redox; RNA

Indexed keywords

AMYLOID BETA PROTEIN; HYDROXYL RADICAL; IRON; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; BRAIN MITOCHONDRION; CYTOPLASM; HUMAN; NERVE CELL; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SENILE PLAQUE;

EID: 1842608804     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1306.015     Document Type: Review

References (27)

1. LOVELL, M.A. et al. 1998. Copper, iron, and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158: 47-52.
2. CONNOR, J.R. et al. 1992. A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J. Neurosci. Res. 31: 75-83.
3. ROBINSON, S.R. et al. 1995. Most amyloid plaques contain ferritin-rich cells. Alzheimer's Res. 1: 191-196.
4. SMITH, M.A. et al. 1998. Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Res. 788: 232-236.
5. SMITH, M.A. et al. 1997. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. USA 94: 9866-9868.
6. BISHOP, G.M. & S.R. ROBINSON. 2001. Quantitative analysis of cell death and ferritin expression in response to cortical iron: implications for hypoxia-ischemia and stroke. Brain Res. 907: 175-187.
7. GARZON-RODRIGUEZ, W. et al. 1999. Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's Aβ peptide studied by fluorescence. Bioorg. Med. Chem. Lett. 9: 2243-2248.
8. MANTYH, P.W. et al. 1993 Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J. Neurochem. 61: 1171-1174.
9. KURODA, Y. & M. KAWAHARA. 1994. Aggregation of amyloid β-protein and its neurotoxicity: enhancement by aluminum and other metals. Tohoku J. Exp. Med. 174: 263-268.
10. ROTTKAMP, C.A. et al. 2001. Redox-active iron mediates amyloid-β toxicity. Free Radical Biol. Med. 30: 447-450.
11. BISHOP, G.M. & S.R. ROBINSON. 2000. β-Amyloid helps to protect neurons from oxidative stress. Neurobiol. Aging 21(suppl. IS): S226.
12. NUNOMURA, A. et al. 2001. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60: 759-767.
13. NUNOMURA, A. et al. 2000. Increasing amyloid Aβ 42 deposition is associated with decreasing neuronal RNA oxidation in Down's syndrome and familial Alzheimer's disease. Brain Pathol. 10: 783.
14. CUAJUNGCO, M.P. et al. 2000. Evidence that the β-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Aβ by zinc. J. Biol. Chem. 275: 19439-19442.
15. SAYRE, L.M. et al. 2000. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J. Neurochem. 74: 270-279.
16. MIYATA, M. & J.D. SMITH. 1996. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet. 14: 55-61.
17. NUNOMURA, A. et al. 1999. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer disease. J. Neurosci. 19: 1959-1964.
18. SHAN, X. et al. 2003. The identification and characterization of oxidized RNAs in Alzheimer's disease. J. Neurosci. 23: 4913-4921.
19. SMITH, M.A. et al. 1994. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am. J. Pathol. 145: 42-47.
20. PREMKUMAR, D.R.D. et al. 1995. Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease. J. Neurochem. 65: 1399-1402.
21. SCHIPPER, H.M. et al. 1995. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann. Neurol. 37: 758-768.
22. KEYSE, S.M. & R.M. TYRRELL. 1989. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc. Natl. Acad. Sci. USA 86: 99-103.
23. HIRAI, K. et al. 2001. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21: 3017-3023.
24. CRAPPER MCLACHLAN, D.R. et al. 1991. Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337: 1304-1308.
25. MCLACHLAN, D.R. et al. 1993. Desferrioxamine and Alzheimer's disease: video home behavior assessment of clinical course and measures of brain aluminum. Ther. Drug Monit. 15: 602-607.
26. PERRY, G. et al. 1998. Reactive oxygen species mediate cellular damage in Alzheimer disease. J. Alzheimer's Dis. 1: 45-55.
27. PERRY, G. et al. 2000. Amyloid-β junkies. Lancet 355: 757.